US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,858 | -3,287 | -2,891 | -3,835 | -2,160 |
| Depreciation Amortization | 685 | 977 | 447 | 441 | 403 |
| Accounts receivable | -4 | -40 | -6 | -76 | -37 |
| Accounts payable and accrued liabilities | 274 | 73 | 150 | 345 | 426 |
| Other Working Capital | 285 | 28 | 141 | 97 | 637 |
| Other Operating Activity | 1,312 | 1,191 | 1,680 | 1,818 | 1,333 |
| Operating Cash Flow | $-305 | $-1,058 | $-479 | $-1,211 | $603 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | N/A | N/A | N/A | 167 | 312 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $167 | $312 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 213 | 856 | 543 | 471 | 350 |
| Common Stock Issued | 85 | 275 | N/A | 50 | 368 |
| Other Financing Activity | -28 | -52 | -46 | -834 | -1,262 |
| Financing Cash Flow | $271 | $1,079 | $498 | $-313 | $-544 |
| Beginning Cash Position | 39 | 19 | N/A | 1,357 | 987 |
| End Cash Position | 5 | 39 | 19 | 0 | 1,357 |
| Net Cash Flow | $-34 | $21 | $19 | $-1,357 | $370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -305 | -1,058 | -479 | -1,211 | 603 |
| Free Cash Flow | -305 | -1,058 | -479 | -1,211 | 603 |